Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Bimatoprost may help treat hair loss from alopecia areata.

Overweight smokers have worse hair loss.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Mange in guinea pigs can be cured with gamma benzene hexachloride washes.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

A young woman with severe symptoms was diagnosed with SLE and improved significantly after treatment.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.